​​Effectiveness of mRESVIA Against Serious Endpoints related to RSV in Kaiser Permanente Northern California (ERASE-RSV)​

Study type

• Study topic:
  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Effectiveness study (incl. comparative)

Non-interventional study

• Non-interventional study design:
  Cohort

Study drug and medical condition

• Medicinal product name:
  MRESVIA
• Study drug International non-proprietary name (INN) or common name:
  RESPIRATORY SYNCYTIAL VIRUS MRNA VACCINE (NUCLEOSIDE MODIFIED)
• Anatomical Therapeutic Chemical (ATC) code:
  (J07BX05) respiratory syncytial virus vaccines

  respiratory syncytial virus vaccines